T
Takeyuki Watadani
Researcher at University of Tokyo
Publications - 44
Citations - 1459
Takeyuki Watadani is an academic researcher from University of Tokyo. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 13, co-authored 33 publications receiving 880 citations.
Papers
More filters
Journal ArticleDOI
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
Naoto Fujiwara,Hayato Nakagawa,Yotaro Kudo,Ryosuke Tateishi,Masataka Taguri,Takeyuki Watadani,Ryo Nakagomi,Mayuko Kondo,Takuma Nakatsuka,Tatsuya Minami,Masaya Sato,Koji Uchino,Kenichiro Enooku,Yuji Kondo,Yoshinari Asaoka,Yasuo Tanaka,Kuni Ohtomo,Shuichiro Shiina,Kazuhiko Koike +18 more
TL;DR: Body composition rather than BMI is a major determinant of prognosis in patients with HCC, and sarcopenia, IMF deposition, and visceral adiposity independently predict mortality in patientsWith HCC.
Journal ArticleDOI
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.
Norihiro Kokudo,Nobuyuki Takemura,Kiyoshi Hasegawa,Tadatoshi Takayama,Shoji Kubo,Mitsuo Shimada,Hiroaki Nagano,Etsuro Hatano,Namiki Izumi,Shuichi Kaneko,Masatoshi Kudo,Hiroko Iijima,Takuya Genda,Ryosuke Tateishi,Takuji Torimura,Hiroshi Igaki,Satoshi Kobayashi,Hideyuki Sakurai,Takamichi Murakami,Takeyuki Watadani,Yutaka Matsuyama +20 more
TL;DR: The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese.
Journal ArticleDOI
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
Satoshi Ebata,Ayumi Yoshizaki,Koji Oba,Kosuke Kashiwabara,Keiko Ueda,Yukari Uemura,Takeyuki Watadani,Takemichi Fukasawa,Shunsuke Miura,Asako Yoshizaki-Ogawa,Yoshihide Asano,Naoko Okiyama,Masanari Kodera,Minoru Hasegawa,Shinichi Sato +14 more
TL;DR: This is the first clinical trial to show efficacy of rituximab with skin sclerosis as the primary endpoint and appears to be an effective and safe treatment for systemic sclerosis, although this study has some limitations.
Journal ArticleDOI
Comparison between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-based Texture Analysis.
TL;DR: Among MR image-based textures, first-order entropy, median, GLRLM-based run length non-uniformity, and run percentage are considered to enhance differences between GBM and PCNSL.
Journal ArticleDOI
Honeycombing on CT; its definition, pathologic correlation, and future direction of its diagnosis
Takeshi Johkoh,Fumikazu Sakai,Satoshi Noma,Masanori Akira,Kiminori Fujimoto,Takeyuki Watadani,Yukihiko Sugiyama +6 more
TL;DR: Honeycombing on CT is the clue for the diagnosis of usual interstitial pneumonia (UIP) and its hallmark, and typical honeycombing is frequently observed in the patients with UIP, so it should be judge clustered cysts as Honeycombing when a diagnosis of UIP is suspected.